These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17653341)

  • 1. Cell-based sensor for analysis of EGFR biomarker expression in oral cancer.
    Weigum SE; Floriano PN; Christodoulides N; McDevitt JT
    Lab Chip; 2007 Aug; 7(8):995-1003. PubMed ID: 17653341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
    Psyrri A; Yu Z; Weinberger PM; Sasaki C; Haffty B; Camp R; Rimm D; Burtness BA
    Clin Cancer Res; 2005 Aug; 11(16):5856-62. PubMed ID: 16115926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa.
    Maiorano E; Favia G; Maisonneuve P; Viale G
    J Pathol; 1998 Jun; 185(2):167-74. PubMed ID: 9713343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer.
    Lo HW; Xia W; Wei Y; Ali-Seyed M; Huang SF; Hung MC
    Cancer Res; 2005 Jan; 65(1):338-48. PubMed ID: 15665312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma.
    Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
    Oral Dis; 2007 May; 13(3):285-90. PubMed ID: 17448210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microfluidic platform for sequential ligand labeling and cell binding analysis.
    Sui G; Lee CC; Kamei K; Li HJ; Wang JY; Wang J; Herschman HR; Tseng HR
    Biomed Microdevices; 2007 Jun; 9(3):301-5. PubMed ID: 17195108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma.
    Sheu JJ; Hua CH; Wan L; Lin YJ; Lai MT; Tseng HC; Jinawath N; Tsai MH; Chang NW; Lin CF; Lin CC; Hsieh LJ; Wang TL; Shih IeM; Tsai FJ
    Cancer Res; 2009 Mar; 69(6):2568-76. PubMed ID: 19276369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
    Chang AR; Wu HG; Park CI; Jun YK; Kim CW
    Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric detection and quantitation of the epidermal growth factor receptor in comparison to Scatchard analysis in human bladder carcinoma cell lines.
    Brockhoff G; Hofstaedter F; Knuechel R
    Cytometry; 1994 Sep; 17(1):75-83. PubMed ID: 8001460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and capture of breast cancer cells using an antibody-based platform in a microelectromechanical systems device.
    Du Z; Cheng KH; Vaughn MW; Collie NL; Gollahon LS
    Biomed Microdevices; 2007 Feb; 9(1):35-42. PubMed ID: 17103049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of EGFR by oral squamous cell carcinoma cell lines.
    Dang D; Sadler S; Ramos DM
    J Calif Dent Assoc; 2009 Dec; 37(12):869-74. PubMed ID: 20066875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the molecular changes associated with oral cancer using a molecular-specific fluorescent contrast agent and single-wavelength spectroscopy.
    Hsu ER; Gillenwater AM; Richards-Kortum RR
    Appl Spectrosc; 2005 Sep; 59(9):1166-73. PubMed ID: 16197641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A parallel-gradient microfluidic chamber for quantitative analysis of breast cancer cell chemotaxis.
    Saadi W; Wang SJ; Lin F; Jeon NL
    Biomed Microdevices; 2006 Jun; 8(2):109-18. PubMed ID: 16688570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease mechanism and biomarkers of oral squamous cell carcinoma.
    Brinkman BM; Wong DT
    Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity.
    Jackson LL; Wade Z; Hessler RB; Abdelsayed R; Rogers JB; Gourin CG
    Laryngoscope; 2007 May; 117(5):868-71. PubMed ID: 17473685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
    Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
    Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
    Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.